Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.

Tramm T, Kim JY, Tavassoli FA.

Am J Surg Pathol. 2011 Feb;35(2):202-11. doi: 10.1097/PAS.0b013e31820598a2.

PMID:
21263240
2.
3.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

4.
5.

Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.

Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ.

Am J Surg Pathol. 2006 Aug;30(8):1002-7.

PMID:
16861972
6.

Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.

Elayat G, Selim AG, Wells CA.

Ann Diagn Pathol. 2010 Feb;14(1):1-7. doi: 10.1016/j.anndiagpath.2009.05.001.

PMID:
20123450
7.

Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.

Kawasaki T, Oyama T, Nakagomi H, Furuya K, Kondo T, Nakazawa T, Mochizuki K, Yamane T, Miyazawa T, Ishii Y, Fukushima K, Moriya T, Tsunoda H, Katoh R.

Pathol Int. 2011 Oct;61(10):615-7. doi: 10.1111/j.1440-1827.2011.02712.x. No abstract available.

PMID:
21951673
8.

Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.

Shim HS, Jung WH, Kim H, Park K, Cho NH.

APMIS. 2006 May;114(5):352-8.

PMID:
16725011
9.

A case of sebaceoma with extensive apocrine differentiation.

Tanahashi J, Kashima K, Daa T, Kondoh Y, Yada N, Kuratomi E, Yokoyama S.

Am J Dermatopathol. 2008 Aug;30(4):408-11. doi: 10.1097/DAD.0b013e31817d2a4a.

PMID:
18645320
11.

Apocrine carcinoma vs. apocrine metaplasia with atypia of the breast. Use of aspiration biopsy cytology.

Yoshida K, Inoue M, Furuta S, Sakai R, Imai R, Hayakawa S, Fukatsu T, Nagasaka T, Nakashima N.

Acta Cytol. 1996 Mar-Apr;40(2):247-51.

PMID:
8629406
12.

Apocrine differentiation in human mammary carcinoma.

Mossler JA, Barton TK, Brinkhous AD, McCarty KS, Moylan JA, McCarty KS Jr.

Cancer. 1980 Dec 1;46(11):2463-71.

13.
14.

Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis.

Agnantis NJ, Mahera H, Maounis N, Spandidos DA.

Eur J Gynaecol Oncol. 1992;13(4):309-15.

PMID:
1325346
15.

Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.

Popnikolov NK, Cavone SM, Schultz PM, Garcia FU.

Mod Pathol. 2005 Dec;18(12):1535-41.

16.

[Apocrine carcinoma of the breast--a morphologic comparison of the apocrine sweat glands and the apocrine metaplastic epithelia in mastopathy].

Tsubura A, Uemura Y, Inui T, Izumi H, Morii S.

Gan No Rinsho. 1988 Jun;34(7):901-7. Japanese.

PMID:
3398262
17.
18.

Apocrine adenoma of the breast.

Cashell AW.

W V Med J. 2008 Mar-Apr;104(2):16-9.

PMID:
18491794
19.

The histologic spectrum of apocrine lesions of the breast.

Durham JR, Fechner RE.

Am J Clin Pathol. 2000 May;113(5 Suppl 1):S3-18. Review.

PMID:
11993707
20.

A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.

Wood A, Houghton SL, Biswas A.

Am J Dermatopathol. 2016 Jul;38(7):475-83. doi: 10.1097/DAD.0000000000000431.

PMID:
26630681

Supplemental Content

Support Center